Diseases of Bone and Mineral Metabolism (posters)

MON-0194

Bariatric Surgery Patients Have Continued Bone Loss for 2 Years after Surgery Despite Weight Stabilization
Elaine W. Yu, Mary L Bouxsein, Elizabeth Monis, Adam Roy, W. Scott Butsch and Joel S Finkelstein

MON-0195

Hyponatremia Is Associated with Increased Osteoporosis and Bone Fragility Fractures in a Large Health System Population
Rachel L. Usala, Stephen J. Fernandez, Laura Cowen, Nawar M. Shara, Julianna Barsony and Joseph G. Verbalis

MON-0196

Cinacalcet Normalizes Serum Calcium in a Randomized, Placebo-Controlled Clinical Study in Patients with Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Aliya Aziz Khan, John P Bilezikian, Henry G Bone, Andrey Gurevich, Peter Lakatos, Waldemar Misiorowski, Liudmila Ya Rozhinskaya, Marie-Louise Trotman and Miklos Toth

MON-0197

Delayed Onset Mild Primary Hypoparathyroidism in Post Thyroidectomy for Thyroid Cancer: A Case Series
Catherine Mary Kelly, Afshan Zahedi, Rosario Briones and Abtin Jafroodifar

MON-0198

Bone and Muscle Health Deficits in Children and Adolescents Treated Long Term with Antiepileptic Medications: A Twin and Sibling Study
Jenning Nuguid, Peter Simm, Jeremy Freeman, Mark MacKay, Alexandra Gorelik, Ashwini Kale, Sandra Petty and John D Wark

MON-0199

PTHrP-Induced Hypercalcaemia: A Series of 138 Cases
Donald SA Mcleod, Peter Justin Donovan, Naomi Achong, Katherine Adele Scott, John Galligan and Carel J Pretorius

MON-0200

SSRI Use in Adolescents Is Associated with Decreased Bone Mass: An Nhanes Study
Alexis Jamie Feuer, Ashley Thai, Ryan T Demmer and Maria George Vogiatzi

MON-0201

Effects of GH/IGF-1 Excess on Bone Metabolism in Patients with Primary Hyperparathyroidism Coexisting with Acromegaly
Naoki Edo, Hisanori Suzuki, Megumi Miyakawa, Akira Takeshita, Noriaki Fukuhara, Hiroshi Nishioka, Daishu Miura, Shozo Yamada and Yasuhiro Takeuchi

MON-0202

The Role of alpha2-Adrenergic Receptors in Human Bone Remodeling
Eelkje J Limonard, Michael W Tanck, Annemieke C Heijboer, Erik Endert, Eric Fliers and Peter H Bisschop

MON-0203

Reasons for Non-Treatment of Osteoporosis Among Postmenopausal Patients in the United States – Physician Perspective
Arun Krishna, Ravi Sadasivan, Kelly Olsson, Jessica Papadopoulos Weaver and Shuvayu Sen

MON-0204

Reasons for Non-Treatment of Osteoporosis Among Postmenopausal Patients in the United States – Patient Perspective
Arun Krishna, Kelly Olsson, Ravi Sadasivan, Jessica Papadopoulos Weaver and Shuvayu Sen

MON-0205

Variable Recovery in Bone Mass at Axial and Appendicular Sites in Indian Lactating Women
Anuradha Khadilkar, Neha Kajale, Shashi Chiplonkar, Zulf M Mughal and Vaman Khadilkar

MON-0206

Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH)
Xiaoping Zhang, Erik Allen Imel, Mary Denise Ruppe, Thomas Joseph Weber, Mark Klausner, Takahiro Ito, Maria Vergeire, Jeffrey Humphrey, Francis H Glorieux, Anthony A Portale, Karl Insogna, Munro Peacock and Thomas O Carpenter

MON-0207

Tumor Induced Osteomalacia; A Single Centre Experience
Nisha Bhavani, Adlyne Reena Ashirvatham, RV Jayakumar, Harish Kumar, Vasantha Nair, Praveen V Pavithran, Arun S Menon and Usha V Menon

MON-0209

Paricalcitol Therapy Improves Hyperparathyroidism in Patients with X-Linked Hypophosphatemia: Results from a One-Year Randomized Controlled Trial
Thomas O Carpenter, Elizabeth A Olear, Jane H Zhang, Bruce K Ellis, Christine A Simpson, David Cheng, Caren M Gundberg and Karl Insogna

MON-0210

Effect of Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) on Quality of Life in X-Linked Hypophosphatemia (XLH)
Mary Denise Ruppe, Xiaoping Zhang, Erik Allen Imel, Thomas Joseph Weber, Mark Klausner, Takahiro Ito, Maria Vergeire, Jeffrey Humphrey, Francis H Glorieux, Anthony A Portale, Karl Insogna, Munro Peacock and Thomas O Carpenter

MON-0212

BONE Loss in Patients Undergoing Hematopoietic STEM CELL Transplant (HSCT)
Narendra Kotwal, Aditi Dilip Pandit and M K Garg

MON-0213

BONE Mineral Density and Quality of Life in Adults with Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone Therapy during 7 YEARS
Myriam Lorena Partida Muñoz, Gonzalo Allo Miguel, Maria Soledad Librizzi, Sonsoles Guadalix Iglesias, Guillermo Martínez Díaz-Guerra, Alicia Serraclara Pla and Federico G Hawkins

MON-0214

One Year Physical Training MAY Atenuate SPINE BONE Loss and Improve Muscle Strengh in Individuals Submitted to Bariatric Surgery
Luciana Campanha-Versiani, Marta MS Sarquis, Danielle Aparecida Gomes Pereira, Adauto Versiani Ramos, Maria de Fatima Haueisen Sander Diniz and Luiz De Marco

MON-0216

Thalassemia Bone Disease: A 19 Year Longitudinal Analysis
Phillip Wong, Peter J Fuller, Matthew T Gillespie, Vicky Kartsogiannis, Donald K Bowden, Boyd J Strauss, Eldho Paul and Frances Milat

MON-0217

Evaluation of a New Pamidronate Protocol for the Treatment of Osteogenesis Imperfecta
Telma Palomo, Maria Cristina Andrade, Barbara S.E. Peters, Fernanda A Reis, João Thomas Carvalhaes, Francis H Glorieux, Frank Rauch and Marise Lazaretti-Castro

MON-0218

Association of Pro- and Anti-Inflamatory Cytokines with Markers of Bone Turnover in Patients with Type 1 Diabetes Mellitus
Ruth Cruz-Soto, Analleli Manguilar-Leon, Victoria Mendoza, Mario Molina-Ayala, Guadalupe Guadalupe, Baldomero Gonzalez, Aldo Ferreira and Moises Mercado

MON-0219

Bone Mass Levels Between Mexican Women with One Pregnancy Only and with Previous Multiple Pregnancies
Ana Martínez Lira, Karen Canchola Benitez and Herlinda Aguilar-Zavala

MON-0220

Bone Mineral Density Is Low in Somalian Women Living in Sweden
Amra Osmancevic, Taye Demeke, Anne Lene Krogstad, Håkan Sinclair, Eva Angesjö, Gamal El-Gawad and Kerstin Landin-Wilhelmsen

MON-0221

Circulating Osteopontin Level Is Reduced Among Type 2 Diabetes with Poor Glycemic Control
Nasser M. Rizk, Amina Saleh Fadel, Nora Basem Younes, Amrita Cheema and Mahmoud Zeiri

MON-0222

Pamidronate Does Not Impair Tooth Formation or Eruption in Children with Osteogenesis Imperfecta
Luiz Claudio Goncalves de Castro, Cinthia Araujo, Andre Leite, Paulo Yamaguti, Heliana Mestrinho and Ana Carolina Acevedo

MON-0224

Preoperative Biochemical Profile Predicts Gland Size and Multifocality in Primary Hyperparathyroidism
Lev David Bubis, James A Lee, Irene Epelboym, Jennifer Hong Kuo, John Chabot and John D Allendorf

MON-0225

Incidence and Clinical Spectrum of Thiazide-Associated Hypercalcemia – a Population-Based Study
Marcio L Griebeler, Ann E Kearns, Matthew A Hathcock, Euijung Ryu, L Joseph Melton III and Robert A Wermers